About
Allergen Desensitization
Areas of Focus
Categories
Biologics & BiopharmaceuticalDrug Delivery & Formulation
Clinical Trials (27)
View allTotal Trials
27
As Lead Sponsor
26
As Collaborator
1
Total Enrollment
13,200
By Phase
PHASE3: 10PHASE2: 4PHASE1: 6PHASE2/PHASE3: 2
By Status
COMPLETED: 22TERMINATED: 3ACTIVE_NOT_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline27 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05668390Lead Sponsor
Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma
PHASE3Active, not recruiting
699 participants
Started: Nov 14, 2023 · Completed: Nov 30, 2025
NCT06574061Lead Sponsor
Evaluation of the Benefits of Sublingual AIT (PRACTIS)
N/ACompleted
1,635 participants
Started: Aug 29, 2018 · Completed: Oct 14, 2021
NCT02443805Lead Sponsor
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
PHASE3Completed
1,607 participants
Started: Sep 29, 2015 · Completed: Jun 25, 2018
NCT03960359Collaborator
Inflammatory and Immune Profiles During a Severe Exacerbation in Preschool Asthmatic Children (<5 Years)
N/AUnknown
150 participants
Started: Feb 24, 2015 · Completed: Feb 28, 2025
NCT02295969Lead Sponsor
Observational Study of Oralair® in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis
N/ACompleted
307 participants
Started: Dec 31, 2014 · Completed: Jul 3, 2017
Locations (1)
Headquarters
Antony, France
Map
Loading map...